Compare Aehr Test Systems (AEHR) vs Ambarella Inc (AMBA) Price & Performance

AEHR trades at $72.33, up 3.38% today, with a bullish technical signal driven by oversold RSI readings near 24.5, though moving averages remain bearish. The company reported Q1 2026 EPS of -$0.05, beating expectations, but maintains negative profitability margins and cash flow. Recent news highlights strong order growth from AI and silicon photonics customers, including a follow-on system order announced June 17, 2026.

Outlook is mixed: robust order book and AI sector tailwinds support growth, but high P/S of 46.6 and persistent losses pose valuation risks. Analyst consensus is cautious with 33% buy ratings. Key risks include execution on orders and cash burn.

Ambarella (AMBA) trades at $79.73, up 1.75% with a bullish technical outlook supported by moving averages. The company shows improving fundamentals with three consecutive quarterly earnings beats and a significant $800M+ long-term edge AI agreement with Hanwha. Revenue grew 16.9% year-over-year in Q1 2027 to $100.4M, though the company remains unprofitable with a -17.18% net income margin. Analyst sentiment is strongly positive with 58% buy ratings and a $108.67 consensus price target representing 36% upside potential.

Ambarella presents a compelling growth story in edge AI with strong analyst support and recent business momentum, but faces execution risks in transitioning to profitability. The stock's current valuation at 8.47x sales appears justified given the company's positioning in the rapidly expanding physical AI market, though investors should monitor progress toward sustainable profitability and competitive pressures in the semiconductor space.